Showing results (361-370 of 389) with videos related to
Sort By:
Pageof 39
Human Genetics|July 1, 1997
Search for the optimal fetal cell antibody: results of immunophenotyping studies using flow cytometryY L Zheng, D K Zhen, M A DeMaria, et al.Bioorganic & Medicinal Chemistry|June 1, 1996
2,5-Diarylisothiazolone: novel inhibitors of cytokine-induced cartilage destructionS W Wright, J J Petraitis, B Freimark, et al.Science (New York, N.Y.)|June 14, 1991
Organic superconductors--new benchmarksJ M Williams, A J Schultz, U Geiser, et al.The Journal of Thoracic and Cardiovascular Surgery|June 1, 1982
Encircling endocardial ventriculotomy for refractory ischemic ventricular tachycardia. I. Electrophysiological effectsR M Ungerleider, W L Holman, T E Stanley, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1987
Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancementW M Padberg, R H Lord, J W Kupiec-Weglinski, et al.Kidney International|April 14, 1999
A laboratory model of toxin-induced hemolytic uremic syndromeC M Taylor, J M Williams, C J Lote, et al.Neuroscience|March 31, 2010
Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activationE A Hackler, N E Byun, C K Jones, et al.Journal of Enzyme Inhibition|January 1, 1996
Comparative effects of selective cyclooxygenase 1 and cyclooxygenase 2 inhibitors on myeloperoxidase and 3 alpha-hydroxysteroid dehydrogenaseN L Rider, D Pinto, M Covington, et al.Glycoconjugate Journal|October 1, 1996
Colonic mucins in ulcerative colitis: evidence for loss of sulfationA P Corfield, N Myerscough, N Bradfield, et al.Molecular Immunology|March 23, 2010
Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisitedS A Johnson, J M Williams, S Hakobyan, et al.Pageof 39